药研社 Yaoyanshe (AI) — Funding, Investors & Signals 2026

药研社 Yaoyanshe

药研社是专注为医疗行业提供创新型医药研发服务的CRO科技平台，以患者为中心，致力于成为医药研发生态最有温度、最可信赖的科技平台。

Founded 2015 China

China 48 employees Series D Total: $900.00M AI, Biotechnology +2

Yaoyanshe is a CRO technology platform that focuses on providing innovative clinical research services for the medical industry. With a patient-centric approach, Yaoyanshe is committed to becoming the warmest and most reliable technological platform in the pharmaceutical R&D ecosystem. Leveraging the core advantages of talent, data, and technology, Yaoyanshe offers one-stop services including CRO, SMO, site start-up (SSU), patient recruitment (PRO), FSP (Functional Service Provider), and intelligent data services to all parties involved in drug development. These services effectively reduce R&D costs and shorten development cycles. The company was founded in 2015 and has received multiple rounds of financing from top-tier investors such as Vision Plus Capital, Matrix Partners China, Genesis Capital, Sequoia Capital, Eastern bell Capital, and GGV Capital. In the last investment round of Series D, Yaoyanshe secured a CNY600.00M investment on 10 August 2020 with GGV Capital as one of the lead investors. The company operates in the Biotechnology, Health Care, and Pharmaceutical industries and is based in China.

Funding Stage	Amount	Investors	Lead Investors	Date
Series D	CNY600.00M	1	GGV Capital	10 Aug 2020
Series C	CNY300.00M	4	Matrix Partners China, Eastern Bell Capital +2	18 Aug 2019
Series B	Undisclosed	3	Vision Plus Capital, Matrix Partners China +1	19 Nov 2018
Series A	Undisclosed	2	Vision Plus Capital, Matrix Partners China	13 Jun 2018
Series A	Undisclosed	1	Vision Plus Capital	20 Nov 2017
Angel Round	Undisclosed	-		01 Dec 2015

Funding Stage

Amount

Investors

Lead Investors

Date

Series D

CNY600.00M

GGV Capital

10 Aug 2020

Series C

CNY300.00M

Matrix Partners China, Eastern Bell Capital +2

18 Aug 2019

Series B

Undisclosed

Vision Plus Capital, Matrix Partners China +1

19 Nov 2018

Series A

Undisclosed

Vision Plus Capital, Matrix Partners China

13 Jun 2018

Series A

Undisclosed

Vision Plus Capital

20 Nov 2017

Angel Round

Undisclosed

01 Dec 2015

FAQ About 药研社 Yaoyanshe

药研社是专注为医疗行业提供创新型医药研发服务的CRO科技平台，以患者为中心，致力于成为医药研发生态最有温度、最可信赖的科技平台。

药研社 Yaoyanshe was founded in 2015.

药研社 Yaoyanshe is headquartered in China.

药研社 Yaoyanshe operates in AI, Biotechnology, Health Care and Pharmaceutical. Its work centres on CRO, SMO, clinical research and innovative drug development.

药研社 Yaoyanshe has approximately 48 employees.

药研社 Yaoyanshe has completed 6 funding rounds, raising a total of $900.00M. The latest funding stage is Series D.

Top alternatives and competitors to 药研社 Yaoyanshe include PharPoint Research, Inc., Sanos Clinic, NJS Associates Company, CRC Pharma, MMS. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.

药研社 Yaoyanshe and PharPoint Research, Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

药研社 Yaoyanshe

General Information

Discover More

About 药研社 Yaoyanshe

Funding Rounds & Investors (6)

药研社 Yaoyanshe Alternatives & Competitors

FAQ About 药研社 Yaoyanshe